The Therapeutic Potential of Blocking Galectin-3 Expression in Acute Myocardial Infarction and Mitigating Inflammation of Infarct Region: A Clinical Outcome-Based Translational Study

Wassim Mosleh, Milind R. Chaudhari, Swati Sonkawade, Supriya Mahajan, Charl Khalil, Kevin Frodey, Tanvi Shah, Suraj Dahal, Roshan Karki, Rujuta Katkar, W. Matthijs Blankesteijn, Brian Page, Saraswati Pokharel, Minhyung Kim, Umesh C. Sharma

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number1177271918771969
Pages (from-to)1–10
Number of pages10
JournalBiomarker Insights
Volume13
DOIs
Publication statusPublished - 3 May 2018

Keywords

  • Galectin-3
  • myocardial infarction
  • inflammation
  • fibrosis
  • PERCUTANEOUS CORONARY INTERVENTION
  • RENOVASCULAR HYPERTENSIVE-RATS
  • HEART-FAILURE
  • DIASTOLIC DYSFUNCTION
  • FIBROSIS
  • DISEASE
  • HYPERTROPHY
  • MACROPHAGES
  • BIOMARKERS
  • MORTALITY

Cite this

Mosleh, W., Chaudhari, M. R., Sonkawade, S., Mahajan, S., Khalil, C., Frodey, K., Shah, T., Dahal, S., Karki, R., Katkar, R., Blankesteijn, W. M., Page, B., Pokharel, S., Kim, M., & Sharma, U. C. (2018). The Therapeutic Potential of Blocking Galectin-3 Expression in Acute Myocardial Infarction and Mitigating Inflammation of Infarct Region: A Clinical Outcome-Based Translational Study. Biomarker Insights, 13, 1–10. [1177271918771969]. https://doi.org/10.1177/1177271918771969